Vycor Medical Inc
VYCO· OTC
Filed Nov 14, 2012 · 10-Q · 45 days after period end · 0001145443-12-001288
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $220.12K | $231.28K | $71.21K |
| Net Income | -$792.11K | -$1.15M | -$356.99K |
| EPS Diluted | -$0.14 | $0.00 | -$0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 14, 2012 · 45 d after period end